Lot certificates published
Plain, secure packaging

parent and analog

Semaglutide vs GLP-1(7-37)

GLP-1(7-37) is the recorded structural reference for semaglutide. Semaglutide carries residue substitutions and a derivatized lysine side chain.

Published: 2026-10-03Library record comparison: 2026-10-03

01

Identity side by side

Recorded molecular identities of Semaglutide and GLP-1(7-37)
Recorded fieldSemaglutideGLP-1(7-37)
Canonical nameSemaglutideGlucagon-like peptide-1 (7-37)
Aliasesnot recordedGLP-1 7-37; GLP-I(7-37); Insulinotropin
Development codesNN9535; NNC 0113-0217not recorded
CAS910463-68-2106612-94-6
UNII53AXN4NNHXPI470C66NT
PubChem CID5684333116133830
Molecular formulaC187H291N45O59C151H228N40O47
Molecular weight (Da)41143355.7
Sequence length (residues)3131
Terminal modificationsFree N-terminus; Free C-terminal carboxylFree N-terminus; Free C-terminal carboxyl
Structural modificationsAib substitution at position 8; Arg substitution at position 34; Lys26 derivatization with a fatty-diacid-containing side chainnot recorded

Semaglutide: nomenclature notes

PubChem lists NN9535 and NNC 0113-0217 as development identifiers for the semaglutide molecular record. WHO Proposed INN List 101 and Recommended List 63 print position 8 in English as 2-amino-2-propanoic acid, without the methyl that their French and Spanish names include; this record keeps Aib, 2-aminoisobutyric acid.

GLP-1(7-37): nomenclature notes

This is the reference scaffold for the acylated GLP-1 analogs in this library, because they retain the C-terminal glycine. 'Both are GLP-1 analogs' is not sufficient for this corpus: which native form an analog is built on determines whether its modification table is right. GSRS UNII PI470C66NT and primary CAS 106612-94-6 describe the free 31-residue peptide represented by PubChem CID 16133830, although the GSRS CID cross-reference points to acetate CID 91820613. Mojsov et al. (PMID 3543057) named this glycine-extended form Insulinotropin; the name does not denote the amidated GLP-1(7-36) form.

02

Recorded modification details

An aligned one-letter sequence is not recorded for this pair. The stored modification and sequence notes are shown below.

Semaglutide

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
Aib substitution at position 8; Arg substitution at position 34; Lys26 derivatization with a fatty-diacid-containing side chain
Stored three-letter notation
His · Aib · Glu · Gly · Thr · Phe · Thr · Ser · Asp · Val · Ser · Ser · Tyr · Leu · Glu · Gly · Gln · Ala · Ala · Lys · Glu · Phe · Ile · Ala · Trp · Leu · Val · Arg · Gly · Arg · Gly
Sequence notes
Thirty-one residues in the conventional GLP-1 7-37 numbering this library keeps for every analog built on that scaffold: the first token is His7 and the last is Gly37, so a position number in this entry is the array index plus six, and Lys26 is the twentieth token. NO one-letter string is published here. Position 8 is Aib, 2-aminoisobutyric acid; written as Ala it would name the native residue this analog exists to replace, and any other letter would name a different amino acid again. The IUPHAR/BPS Guide to Pharmacology (ligand 9724, release 2026.3.1) prints Ala at position 8 in its sequence fields while its structure encodes Aib; FDA GSRS also records Aib there. The backbone is also not the whole molecule: the Lys26 side chain is acylated through two AEEA spacers and a gamma-L-glutamyl unit to a C18 dicarboxylic fatty acid. Summing the thirty-one residues with Aib at position 8 and Arg at position 34, removing thirty waters, then adding two AEEA units, one glutamyl unit and octadecanedioic acid less the four waters of the four amide bonds, gives C187H291N45O59 and an average mass of 4113.64 Da, reproducing the recorded formula exactly and the recorded mass to 0.36 Da. Against the machine-verified GLP-1(7-37) entry that backbone differs by exactly CH2 and N2 — the Aib8 and Arg34 substitutions, and nothing else. That arithmetic is the identity check this record rests on; the automated sequence verifier cannot reach it, because Aib and the acyl side chain are both outside its derivation model.

GLP-1(7-37)

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
not recorded
Sequence notes
Thirty-one residues ending in glycine with a FREE C-terminal carboxyl. Distinct from both the amidated 30-residue form and from GLP-1(1-37). Conventional 7-37 numbering retained: Ala8 is the second residue of the mature peptide, Lys26 the twentieth, Lys34 the twenty-eighth. Mixing numbering systems silently produces incorrect modification records for every analog derived from this scaffold.

03

Recorded mechanisms

These lists show the links recorded in each monograph. An unlisted link does not establish its absence from the molecule’s biology.

Recorded only for Semaglutide

not recorded

Recorded only for GLP-1(7-37)

not recorded

04

Recorded compound classes

Shared recorded links

not recorded

Recorded only for Semaglutide

Recorded only for GLP-1(7-37)

05

References for the relationship

  1. Reference 1

    Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.

    Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T

    Journal of medicinal chemistry · 2015-09-11 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Lau J et al. 2015Study models reported: in vitro; animal (mini-pig) · from the abstract

06

Read the full monographs